Northwest Biotherapeutics, Inc. Share Price
Stocks
NWBO
US66737P6007
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1860 USD | +0.54% |
|
-2.21% | -18.71% |
| 05-15 | Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-21 | Northwest Biotherapeutics Establishes Dedicated Leukapheresis Clinic | CI |
| Market Cap | 307M 269M 248M 232M 436M 29.01B 446M 2.98B 1.15B 14.31B 1.15B 1.13B 49.68B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 403M 353M 326M 304M 572M 38.09B 586M 3.92B 1.51B 18.79B 1.51B 1.48B 65.24B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 11.1x |
| Free-Float |
95.04% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +0.54% | ||
| 1 week | -2.21% | ||
| Current month | -17.88% | ||
| 1 month | -15.68% | ||
| 3 months | -5.82% | ||
| 6 months | -18.24% | ||
| Current year | -18.71% |
| 1 week | 0.18 |  | 0.24 |
| 1 month | 0.18 | | 0.24 |
| Current year | 0.18 | | 0.34 |
| 1 year | 0.18 | | 0.37 |
| 3 years | 0.17 | | 1.09 |
| 5 years | 0.17 | | 2.05 |
| 10 years | 0.14 | | 2.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alton Boynton
CEO | Chief Executive Officer | 82 | 31/05/2007 |
Linda Powers
CEO | Chief Executive Officer | 71 | 07/06/2011 |
Marnix Bosch
CTO | Chief Tech/Sci/R&D Officer | 67 | 31/12/1999 |
| Director | Title | Age | Since |
|---|---|---|---|
Alton Boynton
BRD | Director/Board Member | 82 | 31/12/1997 |
Linda Powers
CHM | Chairman | 71 | 16/05/2007 |
Navid Malik
BRD | Director/Board Member | 57 | 31/03/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 28/08/24 | Don | Founder | 1,000,000 | 0.0826% | ||
| 08/08/24 | Don | Chief Technology Officer | 3,000,000 | 0.2478% | ||
| 07/08/24 | Don | Founder | 1,000,000 | 0.0826% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.54% | -2.21% | -22.47% | -67.25% | 307M | |
| +1.83% | -1.65% | +70.20% | +124.99% | 55.78B | |
| +6.76% | +18.10% | +91.66% | +104.09% | 55.66B | |
| -0.30% | +3.66% | -11.77% | -12.97% | 23.84B | |
| +1.01% | +3.45% | +5.00% | +400.81% | 22.7B | |
| +4.28% | +5.91% | +37.60% | -29.86% | 16.12B | |
| +0.10% | +5.75% | +23.18% | +184.09% | 13.64B | |
| +9.96% | +15.98% | +157.65% | +310.89% | 14.8B | |
| +0.93% | +4.10% | +76.61% | +131.39% | 12.16B | |
| -1.05% | +8.31% | +162.29% | +165.67% | 11.85B | |
| Average | +2.41% | +6.31% | +59.00% | +131.18% | 22.69B | |
| Weighted average by Cap. | +3.14% | +7.69% | +65.91% | +139.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 38.93M 34.09M 31.47M 29.39M 55.32M 3.68B 56.58M 379M 146M 1.82B 146M 143M 6.3B |
| Net income | - | - |
| Net Debt | 96.08M 84.13M 77.66M 72.52M 137M 9.08B 140M 935M 361M 4.48B 361M 353M 15.56B | 125M 109M 101M 94.31M 178M 11.81B 182M 1.22B 469M 5.83B 469M 459M 20.23B |
Employees
105
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/06/26 | US$0.1860 | +0.54% | 350,636 |
| 29/06/26 | US$0.1850 | -4.59% | 7,103,920 |
| 26/06/26 | US$0.1939 | +4.27% | 5,291,119 |
| 25/06/26 | US$0.1860 | -1.66% | 3,237,943 |
| 24/06/26 | US$0.1891 | -0.58% | 1,796,624 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1850USD
Average target price
1.000USD
Spread / Average Target
+440.54%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- NWBO Stock
Select your edition
All financial news and data tailored to specific country editions
